By Tracy Vence | December 4, 2014
GlaxoSmithKline is eliminating 900 US jobs—most in R&D.
By Beth Marie Mole | October 17, 2012
GlaxoSmithKline will share long-sought, raw trial data—but access will be tightly controlled.
Page 1 of 1
Kepler-452b revolves around a sun much like our own.
Multiple consecutive adenosine nucleotides can cause protein translation machinery to stall on messenger RNAs.
In some pathogenic bacteria, certain antibiotic resistance–associated mutations may also confer an unexpected growth advantage.
Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.
View the July 2015 contents.
© 1986-2015 The Scientist